Concepedia

Author

Marina Parisi

University of CataniaORCID

Also Known As

M. S. PARISI, M. S. Parisi, M.S. parisi, MARINA PARISI, Marina Parisi, Marina S. Parisi, Marina Silvia Parisi, Parisi, Marina

53

Publications

374

Citations

10

H-Index

0

Concepts

All Affiliations

University of CataniaPoliclinico Universitario di CataniaTecnologie Avanzate (Italy)Fondazione Vincenzo PansadoroAzienda ospedaliera "Bianchi-Melacrino-Morelli"
MP

About

Marina Parisi is an author at University of Catania.

Marina Parisi

×

9

Publications

209

Citations

9

H-Index

YearCitations

PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy

Alessandra Romano, Nunziatina Laura Parrinello, Piera La Cava,

Expert Review of Molecular Diagnostics

2018

69

Efficacy and Toxicity of Frontline Ponatinib Plus Blinatumomab for Adult Ph+ ALL Patients of All Ages. Intermediate Analysis of the Gimema ALL2820

Sabina Chiaretti, Matteo Leoncin, Loredana Elia,

Blood

2024

30

Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network

Concetta Conticello, Alessandra Romano, Vittorio Del Fabro,

Journal of Clinical Medicine

2019

27

Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database

Lucia Gozzo, Calogero Vetro, Serena Brancati,

Frontiers in Pharmacology

2021

21

Efficacy and safety of tixagevimab‐cilgavimab versus SARS‐CoV‐2 breakthrough infection in the hematological conditions

Andrea Duminuco, Antonella Nardo, Alessandra Orofino,

Cancer

2023

17

Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients

Marina Parisi, Salvatore Leotta, Alessandra Romano,

Journal of Clinical Medicine

2019

14

Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey

Uroš Markovic, Alessandra Romano, Vittorio Del Fabro,

Frontiers in Oncology

2021

11

Erythrocyte glutathione determination in the diagnosis of glucose‐6‐phosphate dehydrogenase deficiency

Argante Bozzi, Marina Parisi, Roberto Ström

IUBMB Life

1996

10

Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data

Lucia Gozzo, Antonella Nardo, Serena Brancati,

Healthcare

2023

10

Page 1